Disease

ACE Inhibitor–Induced AKI

Reduced glomerular perfusion in at-risk patients.

Symptoms

Fatigue, swollen ankles, foamy urine, decreased urine output, persistent itching.

Causes

Diabetes, high blood pressure, glomerulonephritis, polycystic kidney disease, prolonged use of certain medications.

Risk factors

Family history, age 60+, cardiovascular disease, smoking, obesity.

Diagnosis

Blood test (eGFR, creatinine), urine analysis (ACR), kidney imaging, biopsy when indicated.

ACE Inhibitor–Induced AKI is a kidney-related medical condition classified under Toxic disorders. Reduced glomerular perfusion in at-risk patients. This condition may present with various symptoms depending on severity and individual patient factors. Diagnosis typically involves comprehensive medical evaluation including patient history, physical examination, laboratory tests, and imaging studies as appropriate. Treatment approaches are individualized based on disease severity, patient comorbidities, and response to therapy. Regular monitoring and follow-up care are essential for optimal management and prevention of complications. Patients are encouraged to work closely with their healthcare team to develop a comprehensive treatment plan.

Most common questions

Is ACE Inhibitor–Induced AKI preventable?

Many kidney conditions can be slowed or prevented with blood-pressure control, blood-sugar management, hydration and avoiding nephrotoxic medications. Speak to a nephrologist for a personalised plan.

When should I see a specialist?

See a nephrologist if your eGFR is below 60, you have persistent proteinuria, recurrent kidney stones or unexplained kidney function decline.

Can this condition be reversed?

Acute presentations are often reversible with prompt treatment. Chronic forms can usually be stabilised or slowed with appropriate medical therapy and lifestyle changes.